Progesterone antagonists such as CDB-4124 to reduce the pain associated with endometriosis and uterine fibroids

摘要

The compound 21-methoxy-17α-acetoxy-11ß- (4N, N-dimethylaminophenyl) -19-norpregna-4,9-diene-3,20-dione (CDB-4124) for use in reducing the pain associated with endometriosis and uterine fibroids, and for use in reducing the size of endometrial lesions or uterine fibroid, wherein the composition to a woman is administered for a dosing period of at least one month, starting the period of administration during the luteal phase said female menstrual cycle.